Form 4 holding
Chief Financial Officer
Oncology Institute, Inc.
- Security class
- Common Stock
- Shares / value
- 414,801
- Estimated value
- $1,273,439
- Report date
- 21 May 2026
- Price
- $3.07
- Ownership
- Direct
Robert Ross Carter - Chief Financial Officer at Oncology Institute, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- TOI, TOIIW on Nasdaq, DFPH on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Robert Ross Carter since 17 Aug 2025
Reported holdings for Robert Ross Carter in Oncology Institute, Inc.
Form 4 holding
Chief Financial Officer
Oncology Institute, Inc.
- Security class
- Class A Common Stock
- Shares / value
- 235,174
- Estimated value
- $629,090
- Report date
- 21 May 2025
- Price
- $2.68
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
Oncology Institute, Inc.
- Security class
- Common Warrant
- Shares / value
- 4,528
- Estimated value
- $566
- Report date
- 26 Mar 2025
- Price
- $0.1250
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Robert Ross Carter in Oncology Institute, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.